eHealth (NASDAQ:EHTH) Stock

eHealth

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare and Employer and Individual. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.

Support from Other Analysts

News

Initiation

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

ABVX

BITF

COHR

EHTH

VEEV

This Veeva Systems Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Earnings

Penny Stocks

Eurozone

Commodities

Global

Intraday Update

APPF

CRBP

NVVE

PCSA

TKLF

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling over 50 points on Friday

The Dow traded up 0.05% to 38,069.66 while the NASDAQ fell 0.4% to 15,447.78. The S&amp;P 500 also fell, dropping, 0.15% to 4,886.79.

Nasdaq Down Over 50 Points; Colgate-Palmolive Posts Upbeat Results

Small Cap

Movers

ACON

AREB

CIFR

CISS

CLSK

FISI

Intelligent Bio Solutions Inc. - Common Stock

INBS

INTC

IPDN

JAGX

KLAC

LBPH

LUMN

MREO

MVLA

ONCO

PBLA

PRCH

RDZN

REVB

RGEN

SAVE

SGMT

TELL

VERA

YIBO

ZJYL

Shares of Intel Corporation (NASDAQ: INTC) fell sharply during Friday’s session. Intel reported upbeat results for its fourth quarter, but issued a weak forecast for the first quarter.

Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

eHealth Inc

<h3>Gainers</h3>
<ul>
<li>XChange Tec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XHG#NASDAQ">XHG</a>) stock increased by 27.4% to $1.44 during Monday's pre-market session. The market value of their outstanding shares is at $162.1 million. </li>
<li>Stock Yards Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYBT#NASDAQ">SYBT</a>) stock moved upwards by 27.07% to $84.62. The market value of their outstanding shares is at $2.4 billion. </li>
<li>S&amp;T Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STBA#NASDAQ">STBA</a>) shares increased by 26.07% to $44.67. The market value of their outstanding shares is at $1.7 billion. </li>
<li>Hamilton Lane (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLNE#NASDAQ">HLNE</a>) stock moved upwards by 12.46% to $157.18. The market value of their outstanding shares is at $6.5 billion. </li>
<li>Powell Max (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMAX#NASDAQ">PMAX</a>) shares moved upwards by 9.72% to $2.03. The market value of their outstanding shares is at $29.8 million. </li>
<li>Greenpro Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRNQ#NASDAQ">GRNQ</a>) stock increased by 9.52% to $2.07. The company's market cap stands at $15.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>FirstCash Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCFS#NASDAQ">FCFS</a>) shares declined by 29.6% to $75.08 during Monday's pre-market session. The company's market cap stands at $3.3 billion. </li>
<li>RenaissanceRe Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNR#NYSE">RNR</a>) shares declined by 11.29% to $221.83. The market value of their outstanding shares is at $11.5 billion. </li>
<li>ProAssurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) stock decreased by 9.98% to $12.81. The company's market cap stands at $655.3 million. </li>
<li>Vinci Partners Inv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VINP#NASDAQ">VINP</a>) shares fell 8.5% to $8.51. The company's market cap stands at $549.9 million. </li>
<li>Hennessy Advisors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HNNA#NASDAQ">HNNA</a>) stock decreased by 8.39% to $10.6. The market value of their outstanding shares is at $82.4 million. </li>
<li>eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) shares fell 8.33% to $9.03. The company's market cap stands at $267.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-financial-services-stocks/" title="www.benzinga.com/money/best-financial-services-stocks/">www.benzinga.com/money/best-financial-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FCFS

GRNQ

HLNE

HNNA

PMAX

STBA

SYBT

VINP

12 Financials Stocks Moving In Monday's Pre-Market Session

WIIM

eHealth shares are trading higher after the company raised its full-year revenue outlook and adjusted EBITDA guidance.

Guidance

eHealth Raises Full-Year Revenue Outlook From $470M-$495M to $500M-$520M vs $487.43M Est.; Raises Adjusted EBITDA Outlook From $7.5M-$25M to $40M-$55M

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Alliance Global Partners analyst Brian Kinstlinger initiated coverage on Bitfarms Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BITF#NASDAQ">BITF</a>) with a Buy rating and announced a price target of $6. Bitfarms shares closed at $1.99 on Tuesday. <a href="https://www.benzinga.com/quote/KR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS analyst Jonathan Yong initiated coverage on eHealth, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) with a Neutral rating and announced a price target of $5.5. eHealth shares closed at $5.67 on Tuesday. <a href="https://www.benzinga.com/quote/PNW/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Mizuho analyst Steven Valiquette initiated coverage on Veeva Systems Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) with an Outperform rating and announced a price target of $275. Veeva Systems shares closed at $226.46 on Tuesday. <a href="https://www.benzinga.com/quote/KR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst George Notter initiated coverage on Coherent Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) with a Buy rating and announced a price target of $135. Coherent shares closed at $106.54 on Tuesday. <a href="https://www.benzinga.com/quote/KR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JMP Securities analyst Jason Butler initiated coverage on ABIVAX Société Anonyme (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABVX#NASDAQ">ABVX</a>) with a Market Outperform rating and announced a price target of $33. Abivax shares closed at $8.30 on Tuesday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying VEEV stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="584" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04081129/image-35-1024x584.png" alt="" class="wp-image-676364" style="width:635px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04081129/image-35-1024x584.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04081129/image-35-300x171.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04081129/image-35-768x438.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04081129/image-35.png 1097w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42293707/jim-cramer-prefers-this-delivery-giant-over-ups">Jim Cramer Prefers FedEx Over This Delivery Giant That &#8216;Screwed Up A Lot Of Holiday Seasons&#8217;</a></li>
</ul>

UBS analyst Jonathan Yong initiates coverage on eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) with a Neutral rating and announces Price Target of $5.5.

Price Target

UBS Initiates Coverage On eHealth with Neutral Rating, Announces Price Target of $5.5

RBC Capital analyst Frank Morgan maintains eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) with a Sector Perform and lowers the price target from $13 to $11.

RBC Capital Maintains Sector Perform on eHealth, Lowers Price Target to $11

Craig-Hallum analyst George Sutton upgrades eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) from Hold to Buy and raises the price target from $5 to $7.

Upgrades

Craig-Hallum Upgrades eHealth to Buy, Raises Price Target to $7

EHealth shares are trading lower after the company reported worse-than-expected Q3 financial results.

eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) reported quarterly losses of $(1.47) per share which missed the analyst consensus estimate of $(1.28) by 14.84 percent. The company reported quarterly sales of $58.409 million which missed the analyst consensus estimate of $58.557 million by 0.25 percent. This is a 9.75 percent decrease over sales of $64.718 million the same period last year.

Earnings Misses

eHealth Q3 2024 Adj. EPS $(1.47) Misses $(1.28) Estimate, Sales $58.409M Miss $58.557M Estimate

eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) affirms FY2024 sales outlook from $470.00 million-495.00 million to $470.00 million-495.00 million.

eHealth Affirms FY2024 Sales Guidance to $470.00M-495.00M  VS Est. 483.54M

eHealth Secures HITRUST i1 Certification For Carrier Integration Platform, Reinforcing Commitment To Data Protection And Cybersecurity In Healthcare

CLOV

ELEV

GOCO

Biden-Harris Administration Proposes Medicare $2 Drug List Model To Lower Prescription Costs; CMS Seeks Feedback On Sample Drug List And Outreach With Voluntary Participation For Part D Sponsors Starting As Early As Jan 2027; Model To Include Drugs For Common Conditions With Periodic Updates Based On New Generics, Clinical Indications, And Pricing Trends

Deutsche Bank analyst George Hill maintains eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) with a Hold and lowers the price target from $5 to $2.

Deutsche Bank Maintains Hold on eHealth, Lowers Price Target to $2

Craig-Hallum analyst George Sutton maintains eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) with a Hold and lowers the price target from $6 to $5.

Craig-Hallum Maintains Hold on eHealth, Lowers Price Target to $5

eHealth shares are trading lower, reversing after earlier rising on better-than-expected Q2 financial results.

General

eHealth shares are trading higher after the company reported better-than-expected Q2 sales results and issued FY24 revenue guidance above estimates.

eHealth Sees FY24 Revenue $470M-$495M Vs $466.574M Est.

eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) reported quarterly losses of $(1.33) per share which missed the analyst consensus estimate of $(1.14) by 16.67 percent. The company reported quarterly sales of $65.856 million which beat the analyst consensus estimate of $55.024 million by 19.69 percent. This is a 1.37 percent decrease over sales of $66.768 million the same period last year.

Earnings Beats

eHealth Q2 2024 GAAP EPS $(1.33) Misses $(1.14) Estimate, Sales $65.856M Beat $55.024M Estimate

Management

eHealth CEO Fran Soistman To Retire In Early 2025, Co. Commences Search For Successor

Today&nbsp;eHealth, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) (eHealth.com), a leading online private health insurance marketplace, applauded the decision by the Centers for Medicare and Medicaid Services (CMS) to temporarily retain CY2024 agent compensation rates for CY2025. CMS's decision comes in response to preliminary injunctions issued by the US District Court for the Northern District of Texas in the case of Americans for Beneficiary Choice v. HHS.

eHealth Applauds Decision By CMS To Retain 2024 Medicare Compensation Guidelines For 2025

Press Releases

eHealth, Inc. Announces Third Quarter 2024 Results

eHealth, Inc. Presenting at the UBS Global Healthcare Conference

eHealth Wins 2024 Healthcare Marketing Impact Award from Modern Healthcare & Ad Age

Facing Increased Costs, 64% of Medicare Beneficiaries Express Higher Confidence in the Future of Medicare Under a Trump Administration

eHealth, Inc. Updates Guidance for Fiscal Year 2024 Following Strong AEP Performance

eHealth, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

"Iris by eHealth" ICHRA Solution Makes Employer Health Benefits Affordable with Personalized Coverage for Employees

eHealth, Inc. to Hold Fourth Quarter and Fiscal Year 2024 Earnings Call on February 26 at 8:30 a.m. Eastern Time

Modivcare Announces Changes to Board of Directors

Fortrea to Add Erin L. Russell to Board of Directors

FTRE

MODV

SVACU

TVTY

Abacus Life

Arthur J. Gallagher

Aon plc Class A Ordinary Shares (Ireland)

Brown & Brown

The Baldwin Insurance Group, Inc. - Class A Common Stock

Baldwin Insurance

Cheche Group Inc. - Class A Ordinary Shares

Cheche Group

Crawford & Company Common Stock

GoHealth

Goosehead Insurance, Inc. - Class A Common Stock

Goosehead Insurance

Hagerty

Hippo Holdings

Health In Tech, Inc. - Class A Common Stock

Health In Tech

Huize Holding Limited - American Depositary Shares

Huize Holding

Marsh & McLennan Companies, Inc. Common Stock

Marsh & McLennan

Reliance Global Group, Inc. - Common Stock

Reliance Global Group

Ryan Specialty Holdings, Inc. Class A Common Stock

Ryan Specialty Hldgs

SelectQuote

TIAN RUIXIANG Holdings Ltd - Class A Ordinary Shares

Tian Ruixiang Holdings

TWFG

Waterdrop Inc. American Depositary Shares (each representing the right to receive 10 Class A Ordinary Shares)

Comments

eHealth

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga